Patients with breast cancer experience significant weight loss after using GLP-1 receptor agonists, highlighting potential benefits for obesity management in this population.
Chad Fanti, MD
Advertisement
Articles by Chad Fanti, MD
Advertisement
Latest Updated Articles
GLP-1 Receptor Agonist Use and Weight Change in Patients With Breast CancerPublished: August 12th 2025 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Novel T Cell Therapies Yield Decade-Long Remission in Epithelial Cancer
2
Mecbotamab Vedotin Shows Positive OS Results in Soft Tissue Sarcoma
3
FDA Approves Diagnostic Tool for Pembrolizumab Combo in Endometrial Cancer
4
Nivolumab/Ipilimumab Improves Real-World Melanoma Outcomes Vs Pembrolizumab
5
